［1］ 李建,张尧,胡登敏,等.1990-2019年中国人群早发性结直肠癌疾病负担及变化趋势分析［J］.现代预防医学,2022,49(19):3468-3473.
LI J,ZHANG Y,HU DM,et al.Analysis of the burden of disease and changing trends of early-onset colorectal cancer in the Chinese population,1990-2019［J］.Modern Preventive Medicine,2022,49(19):3468-3473.
［2］ BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2024,74(3):229-263.
［3］ 上海市抗癌协会大肠癌专业委员会.结直肠癌早筛、早诊、早治上海方案（2023年版）［J］.中国癌症杂志,2024,34(01):13-66.
Colorectal Cancer Specialized Committee of Shanghai Anti-Cancer Association.Shanghai program for early screening,early diagnosis and early treatment of colorectal cancer (2023 edition)［J］.Chinese Journal of Cancer,2024,34(01):13-66.
［4］ 王井,曹大龙,施恒远,等.蚌埠市结直肠癌社会性筛查结肠镜检查顺应性及影响因素分析［J］.实用预防医学,2024,31(03):330-333.
WANG J,CAO DL,SHI HY,et al.Analysis of compliance and influencing factors of colonoscopy for social screening of colorectal cancer in Bengbu City［J］.Practical Preventive Medicine,2024,31(03):330-333.
［5］ HOGG SJ,BEAVIS PA,DAWSON MA,et al.Targeting the epigenetic regulation of antitumour immunity［J］.Nat Rev Drug Discov,2020,19(11):776-800.
［6］ LUO H,WEI W,YE Z,et al.Liquid biopsy of methylation biomarkers in cell-free DNA［J］.Trends Mol Med,2021,27(5):482-500.
［7］ MATTEI AL,BAILLY N,MEISSNER A.DNA methylation:a historical perspective［J］.Trends Genet,2022,38(7):676-707.
［8］ NISHIYAMA A,NAKANISHI M.Navigating the DNA methylation landscape of cancer［J］.Trends Genet,2021,37(11):1012-1027.
［9］ AKIMOTO N,ZHAO M,UGAI T,et al.Tumor long interspersed nucleotide element-1 (LINE-1) hypomethylation in relation to age of colorectal cancer diagnosis and prognosis［J］.Cancers (Basel),2021,13(9):2016.
［10］ 闫新欣,张熙洋,席少枝,等.DNA甲基化标志物在结肠癌中的表达及其意义研究［J］.中国全科医学,2020,23(S2):184-185.
YAN XX,ZHANG XY,XI SZ,et al.Expression of DNA methylation markers in colon cancer and its significance［J］.Chinese Family Medicine,2020,23(S2):184-185.
［11］ DANESE E,MONTAGNANA M,LIPPI G.Circulating molecular biomarkers for screening or early diagnosis of colorectal cancer:which is ready for prime time［J］.Ann Transl Med,2019,7(21):610.
［12］ 李丹,苏光建,肖燕萍,等.外周血甲基化Septin-9检测对结直肠癌诊断价值的Meta分析［J］.中国免疫学杂志,2017,33(10):1547-1551.
LI D,SU GJ,XIAO YP,et al.Meta-analysis of the diagnostic value of peripheral blood methylation Septin-9 test for colorectal cancer［J］.Chinese Journal of Immunology,2017,33(10):1547-1551.
［13］ 李士杰,刘艳刚,王警,等.外周血Septin9基因甲基化检测在结直肠癌筛查中的应用［J］.中国普通外科杂志,2015,24(12):1756-1760.
LI SJ,LIU YG,WANG J,et al.Application of peripheral blood Septin9 gene methylation test in colorectal cancer screening［J］.Chinese Journal of General Surgery,2015,24(12):1756-1760.
［14］ 郭有新,陈宝刚,刘建伟,等.miR-133b对喉癌细胞增殖、凋亡、侵袭的影响及机制研究［J］.安徽医科大学学报,2019,54(01):90-96.
GUO YX,CHEN BG,LIU JW,et al.Effect of miR-133b on cell proliferation,apoptosis and invasion of laryngeal cancer cells and mechanism［J］.Journal of Anhui Medical University,2019,54(01):90-96.
［15］ PAN Y,QIN J,SUN H,et al.MiR- 485- 5p as a potential biomarker and tumor suppressor in human colorectal cancer［J］.Biomark Med,2020,14(3):239- 248.
［16］ 崔雪琴,马胜辉,冯美聪,等.miRNA-485-5p靶向调控SOX5对结直肠癌细胞增殖、迁移、侵袭的影响分析［J］.标记免疫分析与临床,2023,30(10):1700-1705.
CUI XQ,MA SH,FENG MC,et al.Analysis of the effects of miRNA-485-5p targeting and regulating SOX5 on proliferation,migration and invasion of colorectal cancer cells［J］.Marker Immunoassay and Clinics,2023,30(10):1700-1705.
［17］ 芮静,周少波.miR-1229-5p对人结直肠癌细胞SW480增殖、迁移及侵袭的作用研究［J］.蚌埠医学院学报,2023,48(11):1481-1487.
RUI J,ZHOU SB.miR-1229-5p on proliferation,migration and invasion of human colorectal cancer cells SW480［J］.Journal of Bengbu Medical College,2023,48(11):1481-1487.
［18］ ZHU F,WEI J,HE D,et al.The miRNA125a-5p and miRNA125b-1-5p cluster induces cell invasion by down-regulating DDB2-reduced epithelial-to-mesenchymal transition (EMT) in colorectal cancer［J］.Gastrointest Oncol,2022,13(6):3112.
［19］ WANG J,YAN F,ZHAO Q,et al.Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer［J］.Sci Rep,2017,7(1):4150.
［20］ 黄海芬,贺安,徐小达,等.粪便miRNA-92a表达与粪便隐血试验联合诊断结直肠癌的应用［J］.国际老年医学杂志,2023,44 (05):591-596.
HUANG HF,HE A,XU XD,et al.Fecal miRNA-92a expression and fecal occult blood test for the combined diagnosis of colorectal cancer［J］.International Journal of Geriatrics,2023,44 (05):591-596.
［21］ 彭恬,徐雷鸣.表观遗传修饰与环状RNA在结直肠癌中相互作用的研究进展［J］.上海交通大学学报(医学版),2023,43(02):237-243.
PENG T,XU LM.Progress of the interaction between epigenetic modification and cyclic RNA in colorectal cancer［J］.Journal of Shanghai Jiao Tong University (Medical Edition),2023,43(02):237-243.
［22］ GUO YX,GUO YY,CHEN C,et al.Circ3823 contributes to growth,metastasis and angiogenesis of colorectal cancer:involvement of miR-30c-5p/TCF7 axis［J］.Mol Cancer,2021,20(1):93.
［23］ 马维东,王彤彤,朱启航,等.外泌体中circ_0044366调控肿瘤相关成纤维细胞MMP2的表达促进结直肠癌转移的机制研究［J］.中国癌症杂志,2021,31 (05):397-407.
MA WD,WANG TT,ZHU QH,et al.Mechanism of circ_0044366 in exosomes regulating MMP2 expression in tumor-associated fibroblasts to promote colorectal cancer metastasis［J］.Chinese Journal of Cancer,2021,31 (05):397-407.
［24］ 马锐,田进海,马荣,等.环状RNA hsa_circ_0018574在结直肠癌组织中的表达及其对结直肠癌细胞增殖的影响［J］.肿瘤防治研究,2022,49 (12):1258-1264.
MA R,TIAN JH,MA R,et al.Expression of cyclic RNA hsa_circ_0018574 in colorectal cancer tissues and its effect on colorectal cancer cell proliferation［J］.Tumor Control Research,2022,49 (12):1258-1264.
［25］ 李娟,俞力,马肖,等.circRNA UBAP2在结直肠癌中的表达和对化疗的影响［J］.胃肠病学和肝病学杂志,2023,32(07):752-755.
LI J,YU L,MA X,et al.Expression of circRNA UBAP2 in colorectal cancer and its effect on chemotherapy［J］.Journal of Gastroenterology and Hepatology,2023,32(07):752-755.
［26］ SCHWERDTFEGER M,DESIDERIO V,KOBOLD S,et al.Long non-coding RNAs in cancer stem cells［J］.Transl Oncol,2021,14(8):101-134.
［27］ PONTING CP,OLIVER PL,REIK W.Evolution and functions of long noncoding RNAs［J］.Cell,2009,136(4):629-641.
［28］ 曹强.长链非编码RNA SNHG1对结直肠癌增殖、迁移的影响及调控机制［J］.黑龙江医学,2024,48(04):403-406.
CAO Q.Effects of long chain non-coding RNA SNHG1 on proliferation and migration of colorectal cancer and its regulatory mechanism［J］.Heilongjiang Med,2024,48(04):403-406.
［29］ YE D,HU Y,JING F,et al.A novel SNP in promoter region of RP11-3N2.1 is associated with reduced risk of colorectal cancer［J］.J Hum Genet,2018,63(1):47-54.
［30］ SUGANUMA T,WORKMAN JL.Signals and combinatorial functions of histone modifications［J］.Annual Review of Biochemistry,2011,80 (1) :473-499.
［31］ ZHANG Y,SUN Z,JIA J,et al.Overview of histone modification［J］.Adv Exp Med Biol,2021,1283:1-16.
［32］ YU L,YE F,LI YY,et al.Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis［J］.Carcinogenesis,2020,41(5):678-688.
［33］ YAO B,GUI T,ZENG X,et al.PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling［J］.Genome Med,2021,13(1):154.
［34］ SEARS CL,GEIS AL,HOUSSEAU F.Bacteroides fragilis subverts mucosal biology:from symbiont to colon carcinogenesis［J］.J Clin Invest,2014,124(10):4166-4172.
［35］ PROCTOR LM.The human microbiome project in 2011 and beyond［J］.Cell Host Microbe,2011,10(4):287-291.
［36］ 钟莉华,张德文,朱喜丹,等.结直肠癌患者肠道菌群及粪便SDC2基因甲基化检测意义及其关系研究［J］.实用医院临床杂志,2024,21(03):116-120.
ZHONG LH,ZHANG DW,ZHU XD,et al.Significance and relationship between intestinal flora and fecal SDC2 gene methylation in colorectal cancer patients［J］.Practical Hospital Clinical Journal,2024,21(03):116-120.
［37］ 韩冰琦,王岚.肠道菌群失调与结直肠腺瘤发生机制的研究进展［J］.胃肠病学和肝病学杂志,2024,33(05):614-617.
HAN BQ,WANG L.Research progress on the mechanism of intestinal flora dysbiosis and colorectal adenoma［J］.Journal of Gastroenterology and Hepatology,2024,33(05):614-617.
［38］ WONG CC,YU J.Gut microbiota in colorectal cancer development and therapy［J］.Nat Rev Clin Oncol,2023,20(7):429-452.
［39］ 姜志怡,孙佳春,赵琪,等.肠道菌群在结直肠癌进展中的研究［J］.内科急危重症杂志,2023,29(1):56-60.
JIANG ZY,SUN JC,ZHAO Q,et al.Intestinal flora in colorectal cancer progression［J］.Journal of Emergency and Critical Care in Internal Medicine,2023,29(1):56-60.
［40］ RUBINSTEIN MR,WANG X,LIU W,et al.Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin［J］.Cell Host Microbe,2013,14(2):195-206.
［41］ HU M,WANG Z,WU Z,et al.Circulating tumor cells in colorectal cancer in the era of precision medicine［J］.J Mol Med (Berl),2022,100(2):197-213.
［42］ TSAI WS,YOU JF,HUNG HY,et al.Novel circulating tumor cell assay for detection of colorectal adenomas and cancer［J］.Clin Transl Gastroenterol,2019,10(10):e00088.
［43］ 王立,何维新,谢鹏,等.循环肿瘤细胞在结直肠癌患者手术前后变化及其与肿瘤病理因素相关性［J］.临床军医杂志,2023,51(12):1291-1293.
WANG L,HE WX,XIE P,et al.Changes of circulating tumor cells in colorectal cancer patients before and after surgery and their correlation with tumor pathological factors［J］.Journal of Clinical Military Medicine,2023,51(12):1291-1293.
［44］ 潘荣涛.肺癌患者外周血中循环肿瘤细胞(CTC)与D-二聚体、纤维蛋白原及血小板水平的关系研究［J］.系统医学,2018,3(23):4-6.
PAN RT.Study on the relationship between circulating tumor cells (CTC) and D-dimer,fibrinogen and platelet levels in peripheral blood of lung cancer patients［J］.Systemic Medicine,2018,3(23):4-6.
［45］ KUMAKI Y,OLSEN S,SUENAGA M,et al.Comprehensive genomic profiling of circulating cell-free dna distinguishes focal metamplification from aneuploidy in diverse advanced cancers［J］.Curr Oncol,2021,28(5):3717-3728.
［46］ SUN Y,LI M,REN S,et al.Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastoma［J］.Sci Rep,2021,11(1):5638.
［47］ GAO Q,LIN YP,LI BS,et al.Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER):development and independent validation studies［J］.Ann Oncol,2023,34(5):486-495.
［48］ 闫巍,张能维,徐智,等.结直肠癌患者手术前后循环DNA水平的变化及其意义［J］.中国普通外科杂志,2013,22(12):1627-1630.
YAN W,ZHANG NW,XU Z,et al.Changes in circulating DNA levels in colorectal cancer patients before and after surgery and its significance［J］.Chinese Journal of General Surgery,2013,22(12):1627-1630.
［49］ MISALE S,YAEGER R,HOBOR S,et al.Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer［J］.Nature,2012,486(7404):532-536.
［50］HENRIKSEN TV,TARAZONA N,FRYDENDAHL A,et al.Circulating tumor DNA in stage Ⅲ colorectal cancer,beyond minimal residual disease detection,toward assessment of adjuvant therapy efficacy and clinical behavior of recurrences［J］.Clin Cancer Res,2022,28(3):507-517.